Prudential PLC Eli Lilly & CO Transaction History

Prudential PLC

$19.6 Billion
Q3 2024

A detailed history of Prudential PLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Prudential PLC holds 76,053 shares of LLY stock, worth $59.7 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

76,053

Previous 73,930 2.87%

Holding current value

$59.7 Million

Previous $66.9 Million 0.66%

% of portfolio

0.34%

Previous 0.47%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $1.64 Million - $2.04 Million	2,123 Added 2.87%	76,053 $67.4 Million
Q2 2024 Aug 06, 2024	BUY	$724.87 - $909.04 $4.88 Million - $6.12 Million	6,731 Added 10.02%	73,930 $66.9 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $9.65 Million - $12.9 Million	16,289 Added 32.0%	67,199 $52.3 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $1.27 Million - $1.5 Million	2,425 Added 5.0%	50,910 $29.7 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $582,498 - $803,061	-1,340 Reduced 2.69%	48,485 $26 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $3.22 Million - $4.3 Million	-9,168 Reduced 15.54%	49,825 $23.4 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $397,606 - $466,969	-1,280 Reduced 2.12%	58,993 $20.3 Million
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $7.22 Million - $8.41 Million	22,444 Added 59.33%	60,273 $22.1 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $634,467 - $723,041	2,140 Added 6.0%	37,829 $12.2 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $551,606 - $647,667	-1,979 Reduced 5.25%	35,689 $11.6 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $4.6 Million - $5.72 Million	19,596 Added 108.43%	37,668 $10.8 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $1.53 Million - $1.9 Million	6,801 Added 60.34%	18,072 $4.99 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $330,184 - $406,337	-1,490 Reduced 11.68%	11,271 $2.6 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $123,857 - $160,208	-686 Reduced 5.1%	12,761 $2.93 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $1.88 Million - $2.44 Million	-11,454 Reduced 46.0%	13,447 $2.51 Million
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $286,359 - $378,922	-2,195 Reduced 8.1%	24,901 $4.2 Million
Q3 2020 Oct 30, 2020	SELL	$146.22 - $169.13 $187,746 - $217,162	-1,284 Reduced 4.52%	27,096 $4.01 Million
Q2 2020 Jul 31, 2020	BUY	$136.42 - $164.18 $271,748 - $327,046	1,992 Added 7.55%	28,380 $4.66 Million
Q1 2020 May 01, 2020	BUY	$119.05 - $147.35 $2.92 Million - $3.62 Million	24,568 Added 1349.89%	26,388 $3.66 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $399,132 - $494,361	-3,733 Reduced 67.22%	1,820 $239,000
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $338,310 - $367,994	-3,168 Reduced 36.33%	5,553 $622,000
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $6.37 Million - $7.44 Million	-57,497 Reduced 86.83%	8,721 $968,000
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $4.71 Million - $5.54 Million	-42,296 Reduced 38.98%	66,218 $8.59 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $4.72 Million - $5.29 Million	-44,610 Reduced 29.13%	108,514 $12.6 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $2.04 Million - $2.55 Million	-23,728 Reduced 13.42%	153,124 $16.4 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $16,502 - $18,939	-218 Reduced 0.12%	176,852 $15.1 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $817,274 - $964,738	11,013 Added 6.63%	177,070 $13.7 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $149,130 - $159,959	-1,820 Reduced 1.08%	166,057 $14 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $803,377 - $891,668	10,424 Added 6.62%	167,877 $14.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	157,453	157,453 $13 Million

Others Institutions Holding LLY

# of Institutions

4,033

Shares Held

737M

Call Options Held

8.26M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $746B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.

Account